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Neisseria meningitidis: HISTORY AND INTRODUCTION  
 
The meningococcus and meningococcal disease have been of interest to scientists for more 
than 100 years. To depress the frequency of mortality from meningococcal disease, a deeper 
understanding of the physiology and adaptability of the meningococcus and of the mechanisms 
of microbial pathogenicity is necessary.  
Meningococcal disease was first described as “epidemic cerebrospinal fever” by Vieusseaux in 
1805 (Vieusseaux, 1805). However, it was not until 1887 that Anton Weichselbaum in Vienna 
isolated the meningococcus from cerebrospinal fluid (Weichselbaum, 1887). In 1898 
Councilman and co-workers firmly established the etiologic agent of epidemic cerebrospinal 
meningitis when they found meningococcus in the cerebrospinal fluid of 31 of 34 cases 
(Councilman et al., 1898). 
Although much has been written about this gram-negative pathogen and the variety of clinical 
manifestations of meningococcal disease, little is known of the direct relationship between the 
physiology and the biochemistry of the microbe, on the one hand, and the pathogenesis of 
disease on the other.  
The vast literature on meningococci stems from a curiosity about this bacterium, which 
harmlessly inhabits the oropharynx of a portion of the normal population without overt 
symptoms of disease, yet is one of the fastest killers of humans among biological agents. 
Paradoxically, the meningococcus can cause low-frequency sporadic disease in the population 
or large and fast-spreading epidemics. Moreover, the clinical manifestation of meningococcal 
disease may vary greatly as well, from those associated with chronic meningococcemia at the 
one extreme (Sanders et al., 1968) to those of fulminant meningococcal disease with associated 
coagulopathy on the other. The pathological picture also varies widely, depending on the 
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severity of the disease, from relatively insignificant to the involvement of all major organs 
including the brain. 
Neisseria meningitidis is gram-negative and can appear as a single coccus or diplococcus. The  
flattened adjacent sides give the organism the typical “biscuit” or “kidney bean” shape when a 
fresh specimen is examined (Fig. 1).  
 
 
 
Figure 1. Electron micrograph of Neisseria meningitidis 
 
 
It is important that laboratory processing be done rapidly because autolysis occurs with this 
organism. Although meningococci are not as nutritionally fastidious as gonococci, specimens 
from patients with possible meningococcal disease must be cultured on enriched media. If 
inoculated promptly, meningococci will grow on many different solid media such as blood 
agar, supplemented chocolate agar, Muller-Hinton agar, or GC-agar (GonoCoccal agar). In 
addition, Thayer Martin media can be used for oropharyngeal cultures. Neisseria species are 
fastidious in their growth conditions, and all media should be incubated at 35°C to 37°C under 
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increased carbon dioxide content (3% to 10%) and humidity. The final identification of this 
organism is confirmed by a characteristic carbohydrate fermentation pattern (dextrose-positive, 
maltose-positive, and sucrose-negative) and being oxidase-positive or by direct latex 
agglutination testing. 
The meningococcus produces a capsular polysaccharide that is the basis of classifying this 
organism into 13 different serogroups. The serogroups A, B, C, X, Y, Z, 29-E, W-135, and a 
newly described serogroup, L, have well-characterized capsular polysaccharides (Ashton et al., 
1983). The capsular polysaccharides of serogroups D, H, I, and K have not been fully 
characterized. 
Of these, five serogroups (A, B, C, Y, and W-135) are responsible for most of the disease 
worldwide (Peltola, 1983). Meningococci can be further subdivided into serotypes and sub-
serotypes by the detection of serologically distinct epitopes present on their class 2 or class 3 
(PorB) and class 1 (PorA) OMPs (other membrane proteins) (Frash et al., 1985). The 
population biology of meningococci has been also studied by multilocus enzyme 
electrophoresis and multilocus sequence typing. Despite the genetic diversity of the organisms, 
a few electrophoretic types, such as subgroup I, subgroup III, ET-5, ET-37, lineage 3, and 
cluster A4, are repeatedly identified from invasive disease cases (Caugant, 2001).  
The meningococcus may possess the ability to develop pili, which can enhance attachment to 
pharyngeal cells of the host (DeVoe, 1982). This ability may influence the epidemiology and 
pathogenicity of this organism.  
The importance of a bactericidal antibody and an intact complement system in protecting a 
host from meningococcal infection is well documented. Goldschneider and associates have 
shown that in persons with exposure to the organism who lack a serum bactericidal antibody to 
the infecting strain, there is a 30% to 50% chance of meningococcal disease developing 
(Goldschneider, et al., 1969). This lytic antibody is directed primarily against the capsular 
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polysaccharide and forms the basis for the development of potentially effective vaccines. In 
addition, lytic antibody has been found to be directed against noncapsular antigens, accounting 
for most of the “natural immunity” to meningococcal disease (Goldschneider, et al., 1969; 
Reller et al., 1973). 
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EPIDEMIOLOGY OF THE NEISSERIAL INFECTION 
 
The meningococcus has its natural habitat in the mucous membranes of the oropharynx of 
normal human hosts. Those harbouring the organism are usually asymptomatic and are 
commonly referred to as “carriers”. The frequency of carriage in the normal population ranges 
from 5% to 30% (Griffiss & Artenstein, 1976) during nonepidemic periods but may approach 
100% during epidemics.  
The oropharynx serves as the reservoir for the spread of meningococcal infection within the 
population; the microorganism is disseminated by means of aerosols (Artenstein, et al., 1968; 
Glover, 1918; 1920). Airborne organisms impinge on the mucus-covered surfaces of the 
oropharyngeal cells, where they adhere and establish a population. As human beings are the 
only natural host for the meningococcus (Griffiss & Artenstein, 1976), it seems reasonable to 
assume that there is some unique property in the human throat, such as a specific receptor, that 
allows the colonization of the human oropharyngeal mucosa but not that of animals.  
The colonization of the oropharynx by meningococci elicits host antibodies of the three major 
immunoglobulin classes within 7 to 10 days (Goldschneider, et al., 1969). In many instances 
such antibodies seem unable to eliminate the microorganism from the oropharynx, since the 
host may remain a carrier of a specific strain for weeks or even months (Gotschlich et al., 
1969). 
As approximately 50% of meningococcal isolates taken from the oropharynx appear to be 
noncapsulated (Frasch & Robbins, 1978), it is possible that such strains can survive prolonged 
carriage in the presence of serum antibodies. Investigators found that those harbouring 
gonococci had twice the incidence of meningococcal carriage, suggesting a general 
susceptibility to the carriage of, or perhaps infection by, pathogenic Neisseriae (Ødegaard & 
Gedde-Dahl, 1979). 
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During both epidemic and nonepidemic periods, there is a seasonal fluctuation  in which the 
mean monthly incidence is most often at its lowest during the summer and early fall and peaks 
during February, March, or April in the northern hemisphere (May, 1980). Age-specific attack 
rates decrease with age. Most cases occur in children younger than 5 years, and slightly more 
males than females are affected.  In addition, overcrowding and poor living conditions 
predispose persons to meningococcal infection and disease. Contacts of patients with 
meningococcal infections who sleep and eat in the same household have a significantly 
increased risk of  developing the disease compared with the general population, and they must 
receive chemoprophylaxis. 
The endemic rate of meningococcal disease in the United States over the past 40 years has 
varied from 1 to 3 per 100,000. Attack rates during epidemics can exceed 100 cases per 
100,000 population (CDC: Centers for Disease Control, MMWR, 1981; 1985). 
In Italy, the annual incidence of meningococcal disease is of 3-6 cases per 1,000,000 per year. 
In 2001 there were 203 cases of meningococcal meningitis, in 2002 were reported 225 cases, 
and 131 cases in 2003 (data Istituto Superiore di Sanità, Roma, Italy).  
Meningococcal disease has been the focus of increasing attention recently due to its changing 
patterns and the apparent rise in its incidence in several parts of the world where it was not 
considered previously to be a public health problem. Meningococcal disease continues to be a 
problem in Africa, and at the same time, deaths due to this disease have risen during the past 
10 years in South America, the Middle East, Southern Africa, Europe, and Asia (Aymes et al., 
1976). Most of these outbreaks around the world are caused by serogroups A and C (Fig. 2). In 
Italy, since 1999 the proportion of serogroup C Neisseria meningitidis organisms has been 
increasing while the proportion of serogroup B organisms, which have predominated in the 
past, has decreased. Recently 46% of the organisms were serogroup C.  
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Before the advent of sulfonamides, the case-fatality ratio for meningococcal disease was 75% 
to 90 % (Bauks, 1948), but with vigorous antimicrobial treatment the case-fatality ratio can be 
brought below 15%. At present, antibiotic sensitivity testing indicates that circulating Neisseria 
meningitidis strains are resistant to sulfadiazine but sensitive to rifampin, which is used in 
chemoprophylaxis. 
 
 
 
Figure 2. Meningococcal disease in the world  
 
The area with frequent epidemics of meningococcal meningitis (sub-Saharan zone) is 
evidenced in red. 
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MENINGOCOCCAL DISEASE: PHYSIOLOGY AND PATHOGENESIS 
 
Protective antibodies may be acquired either passively by transplacental passage of 
immunoglobulins or actively as the result of oropharyngeal infection with both capsulated and 
noncapsulated meningococci (Goldschneider, et al., 1969; Reller et al., 1973). Moreover, one 
cannot rule out subclinical systemic infections as a mechanism for active immunization. The 
effect of passively acquired immunity is relatively short lived but is effective in protecting 
infants against meningococcal disease, as evidenced by the low incidence of cases in the first 6 
months of life (Smith, 1954). The susceptibility to disease increases progressively during the 
first 6 months of age (Goldschneider, et al., 1969), which correlates with the progressive 
decrease in bactericidal activity of sera. The lowest levels of serum bactericidal activity are 
found between 6 months and 2 years of age, which accounts for the high incidence of 
meningococcal disease within this age group. Moreover, the progressive reduction in the 
incidence of disease after 24 months of age correlates with the rise in serum bactericidal 
activity in children, with adult levels of antibodies developing by the age of 10 years (Frasch, 
1977). 
Protection against meningococcal disease may also result from exposure to cross-reactive 
antigens from bacteria which bear little or no taxonomic relationship to meningococci. For 
example, the capsular polysaccharide from Escherichia coli strain O7:K1(L):NM is 
immunologically and chemically indistinguishable from that of the group B meningococcus 
(Kasper et al., 1973). Furthermore, Bacillus pumilis antigens cross-react with those of group A 
meningococci (Robbins et al., 1974).  
The characteristics of the strains of Neisseria carried by adult and children differ markedly. 
The reasons for this difference are not readily apparent but may stem from the variation 
between adults and children in the oropharyngeal surface environments, i.e., availability of 
microbial nutrients, nature of microbial attachment sites on hot cell surface, etc.  
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According to all data currently available the meningococcus can establish a systemic infection 
only in human hosts that lack serum bactericidal antibodies directed against capsular or 
noncapsular antigens of the invading strain, or in patients deficient in certain complement 
components (Frasch, 1979; Goldschneider, et al., 1969). That the bactericidal activity in serum 
of immune hosts is complement mediated is evidenced by the repeated episodes of 
meningococcal infections in patients lacking the higher complement components C5, C6, C7, 
and C8, which are required for immune bacteriolysis (Lee et al., 1978; Lee et al., 1979; Lim et 
al., 1976; Nicholson & Lepow, 1979; Petersen et al., 1979). Moreover, those deficient in IgM 
appear to be at greater risk from meningococcal infections than normal hosts (Hobbs et al., 
1967; Jones et al., 1973). The IgM antibody has been identified as the primary one involved in 
immune bacteriolysis of gram-negative bacteria (Evans et al., 1966; Michael et al., 1962; 
Michael et al., 1963).  
The meningococcus is thought to enter the systemic circulation directly from the oropharynx. 
The establishment of growth in the deeper tissues or systemic circulation of the susceptible 
host follows the onset of carrier acquisition by only a few days and only rarely do susceptible 
patients have a prolonged oropharyngeal carriage before the onset of overt signs of disease 
(Artenstein, 1967; Murray, 1929). The invasion of the blood stream is preceded by an overt 
oropharyngitis in about one-third of the cases, but the role of the meningococcus as a causative 
agent in pharyngitis has not been determined (Bauks, 1948).  
Once the meningococcus has entered the systemic circulation of the susceptible host and has 
established a population, one of the several faces of meningococcal disease will make itself 
manifest. Upon the primary colonization of the oro- or nasopharynx (carrier state) the 
bacterium enters the blood stream and gives rise to meningococcemia. Concomitantly with the 
bacteremia, or at various times thereafter, the meningococci metastasize to the skin, eyes, 
joints, heart, adrenals, or  meninges and produce various clinical symptoms (Fig. 3). In 90% of 
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cases, meningococcal disease will progress to an inflammation of the leptomeninges (pia and 
arachnoid) with associated dermal lesions (petechiae or the larger purpura) in approximately 
half the cases (Swartz & Dodge, 1965).  
The neisserial infection is a multifactorial process, and involves a series of receptor-mediated 
interactions between the bacteria and the primary target cells. The formation of pili is a 
prerequisite for attachment to the epithelial cell surface. The surface-attached bacteria often 
penetrate the epithelial cells and, whilst contained in a vacuole, may transcytose towards 
subepithelial tissues. The pathogenic Neisseriae strongly interact with phagocytic cells, such as 
neutrophils and macrophages, which seem to provide them with an intracellular habitat (Meyer 
et al., 1994).  
The organism is capable of adapting to growth in a variety of host environments. Moreover, the 
clinical response of the host to meningococcal invasion can vary from a relatively benign 
picture to the extreme of fulminating meningococcemia with death in hours. The microbial 
mechanisms in the pathogenicity of the various forms of meningococcal disease are complex 
and well adapted to evading the host responses to the invading microbe.  
In their simplest form the requirements for microbial survival upon entry into body fluids or 
tissues do not differ greatly from those any microbe faces in a new environment except that the 
animal host has a preprogrammed response against invading organisms. Successful pathogens, 
such as the meningococcus, must have mechanisms to overcome such responses of the host. 
The fatality rate in meningococcal disease before the age of antibiotic therapy was sufficiently 
high (75 to 90%) for one to conclude that the meningococcus does posses the required 
mechanisms to overcome or evade all host defences (DeVoe, 1982). Most literature treats 
virulence of the meningococcus as fixed property in given strains. Virulent strains are 
considered to be those which in low numbers cause disease in some animal model, whereas 
avirulent strains are those that are either incapable of producing disease in an animal model or  
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Figure 3. Infection cycle of Neisseria meningitidis 
After colonizing the nasopharynx, the bacteria adhere to pili and cross the nasopharyngeal 
epithelium by a process of endocytosis to invade the circulatory system. In the bloodstream, 
the bacteria proliferate and adapt to the host environment. Clinical responses to infection are 
varied from a benign form to extreme, fatal forms (meningococcaemia). In its most severe 
form, heightened levels of bacteria in the blood make their way to the meninges in the brain 
and at such high levels of cytotoxicity, induce inflammation of the meninges and progression 
of the disease. 
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require relatively large numbers of organisms to do so. The observation that most hosts can 
harbour “virulent” serotypes of meningococci in the oropharynx but show no overt signs of 
disease is interpreted in the framework of a strong host defence (bactericidal antibody) 
specifically directed at, or cross-reacting with, the meningococcus. On the other hand, during 
epidemics only certain serotypes are routinely isolated from diseased patients, suggesting that 
such microbes possess certain fixed virulence properties. The evidence in support of both 
serum bactericidal host resistance and the virulence associated with specific serotypes is 
convincing and has gained general acceptance. In contrast, the spectrum of manifestations of 
meningococcal disease during epidemics has not been adequately explained. It is possible that 
certain patients have little or no defence whatever against the invading meningococci and, 
therefore, fall victim to fulminating meningococcemia, whereas others with stronger defences 
have less severe forms of the disease.  The past histories of those with fulminating disease do 
not support the conclusion, however, that they were unable to defend against bacterial 
infections in general. Therefore, one must consider either a transitory anergy, such as that 
brought on in some patients by surgery or traumatic injury (McLoughlin et al., 1979), or a 
more virulent organism that can evade host defences, obtain required nutrients from the host 
more efficiently, or both. There is no evidence to support a transient state of anergy associated 
with the onset of meningococcemia. However, there is evidence that environmental changes 
around the meningococcus can greatly influence the metabolism and phenotypic expression of 
the organism. Brener et al. grew a strain of meningococcus at its lowest tolerable pH (6.6) and 
under conditions of iron starvation. The phenotype of the meningococci grown at low pH and 
limited for iron in Mueller-Hinton broth changed dramatically as compared to those grown 
under routine iron-sufficient conditions at neutral pH. The relative virulence index for the 
mouse increased 1,200-fold from a 50% lethal dose of 3,600 to one of 4 organisms. In vitro 
experiments showed the bacteria to be resistant to phagocytosis by both mouse and rabbit 
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PMNs, whereas the same strain grown conventionally was readily phagocytosed (Brener et al., 
1981). 
There is also some indirect evidence for meningococcal phenotypic shifts in vivo. Griffiss et al. 
reported a recurrent infection in a child who developed bactericidal antibody against the 
invading strain. In the recurrence the serotype and serogroup were identical, leading the 
authors to suggest that in vivo alterations in the meningococcus were the result of 
environmental changes in the host (Griffiss et al., 1974).  
There are, no doubt, other phenotypic changes that occur as a result of iron starvation or low 
pH or both. Cells grown at low pH may be more stable and less susceptible to autolysis 
because the peptidoglycan in less prone to hydrolysis at low pH (Wegener et al., 1977). 
However, the most dramatic phenotypic change expressed after growth of meningococci in 
iron-limited media was the expression of a highly efficient mechanism to remove iron from 
human transferrin, the only ready source of iron in the blood (Simonson et al., 1982). The 
metabolic responses of pathogenic Neisseriae to the low pH and low iron are substantial. These 
changes would contribute to the survival potential in the host. It would appear that the 
organisms respond metabolically to the inflammatory reaction in the host by becoming 
stronger and more virulent. 
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MENINGOCOCCAL DISEASE: PREVENTION AND PROPHYLAXIS 
 
 
A polysaccharide vaccine against disease by N. meningitidis serogroups A, C, Y, and W-135 is 
currently licensed. The vaccine consists of 50 μg of the respective purified bacterial capsular 
polysaccharides (Meningococcal vaccine. MMWR, 1985). The serogroup A polysaccharide 
induces antibody in some children as young as 3 months, although a response comparable to 
that seen in adults is not achieved until 4 or 5 years of age; the serogroup C component does 
not induce a reliable antibody response before 2 years of age. A booster response after a second 
dose occurs with group A vaccine but not with group C vaccine (Lepow et al., 1986). 
Serogroup A vaccine has been shown to have a protective efficacy of 85% to 95% and to be 
useful in controlling epidemics. A similar level of clinical efficacy has been shown for the 
serogroup C vaccine. The groups Y and W-135 polysaccharides have been shown to be safe 
and immunogenic in adults and in children older than 2 years. Antibodies, against the group A 
and C polysaccharides, decline over the first three years following a single dose of vaccine. 
This antibody decline is more rapid in infants and young children than in adults.  
Except for the military population, routine vaccination with a meningococcal polysaccharide 
vaccine is not recommended because the risk of infection is substantially low; a vaccine 
against serogroup B, the major cause of meningococcal disease is not yet available; and much 
of the meningococcal disease occurs among children too young to respond to the current 
vaccines. In an outbreak of meningococcal disease, however, the serogroup should be 
identified and the population at risk determined. Older children, adolescents, and young adults 
at high risk may warrant vaccination if the outbreak is caused by one of the serogroups 
included in the vaccine (Meningococcal vaccine. MMWR, 1985). 
Routine immunization with the quadrivalent vaccine (groups A, C, Y, and W-135) may be 
indicated for certain immunodeficient patients at high risk for meningococcal disease, such as 
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patients with specific complement deficiencies and anatomic or functional asplenia, although 
clinical efficacy has not been documented. The use of the vaccine should be considered to 
control outbreaks of disease caused by serogroups represented in the vaccine, and its use may 
be of benefit to travellers to countries recognized as having hyperendemic or epidemic disease 
as well as to persons living in epidemic areas who will have prolonged contact with the local 
population. The vaccine is currently given to all recruits. For both adults and children, vaccine 
is administered subcutaneously as a single 0.5 ml dose. Good antibody levels are achieved 
within 10 to 14 days. Specific immunity occurs from a single dose in 89% to 100% of 
vaccinations (Fulginiti, 1985). The duration of immunity is not known, and the need for 
booster doses remains to be determined, but revaccination after two or three years may be 
indicated for persons at high risk of infection, particularly children who were first immunized 
before 4 years of age. The meningococcal vaccines appear to be safe; localized erythema may 
occur and last one to two days, but no serious adverse effects are known.  
Antimicrobial chemoprophylaxis of intimate contacts remains the primary preventive measure 
in sporadic cases of N. meningitidis disease because as many as half of the secondary cases of 
meningococcal infection occur after five days. Chemoprophylaxis using either rifampin or 
minocycline hydrochloride has been recommended; sulfonamides may be used if the infecting 
strain is known to be susceptible. Household, day-care centre and nursery school contacts 
should receive antibiotic prophylaxis as soon as possible, preferably within 24 hours of the 
diagnosis of the primary case. Chemoprophylaxis is not routinely recommended for medical 
personnel except for those with intimate exposure. Systemic antimicrobial therapy for 
meningococcal disease does not reliably eradicate nasopharyngeal carriage of N. meningitidis 
(Fulginiti, 1985). 
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INFECTION FROM A CELL BIOLOGY POINT OF VIEW: 
PATHOGENIC NEISSERIAE AND DETERMINANTS OF VIRULENCE 
 
The pathogenic Neisseriae produce diverse molecules (determinants of virulence) that can 
interact with host cells. However, the expression of these determinants varies widely among 
the members of an infecting population, even if the population begins as a clonal isolate. Two 
general types of variation occur. In phase variation, the control of expression is binary: on or 
off. In antigenic variation, the variant protein changes in primary sequence. Both types of 
variation occur through hereditable genetic mechanisms, which have been studied intensively 
and are reviewed subsequently.  
The Neisseriae initiate infection by attaching to host cells via surface-associated filaments 
called type IV pili. The pili, fine, hair-like organelles protruding from the bacterial cell surface, 
probably represent the most variable structures produced by the pathogenic Neisseriae. In the 
bacterial genome multiple gene copies exist most of which are unexpressed, incomplete 
(silent/cryptic) gene copies (pilS), while only one or two of these represent the expressed gene 
copies (pilE). The pilS copies constitute the variant sequence repertoire which is used for 
recombination with pilE to generate variant pilin molecules. Owing to this remarkable 
variability, the bacterial pili can effectively escape the human immune response, since the 
variability of antibodies and T cell receptors of the immune system, which uses a similar 
variation mechanism, is within the same order of magnitude. Recent studies have provided 
evidence that recombination of pil genes can occur by at least four pathways, i.e., reciprocal, 
nonreciprocal (gene conversion-like), transformation-mediated recombination and deletion of 
duplicated gene copies (Haas and Meyer, 1986; Manning et al., 1991; Swanson et al., 1986; 
Seifert et al., 1988; Gibbs et al., 1989; Hill et al., 1990; Zhang et al., 1992; Facius & Meyer, 
1993). The pili are an absolute requirement for the initiation of an infection (Kellogg et al., 
1968) in that they confer the attachment of the bacteria to epithelial cells (McGee et al., 1981; 
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Stephens & McGee, 1981). The binding of pili appears to be specific for human cells and the 
pili therefore represent a major determinant of the neisserial species tropism. Owing to their 
exposed location they are also strong targets for an antibody response that could interfere with 
receptor recognition.  
Early studies suggested a direct role for pilin (PilE), the major subunit, in adherence to various 
cellular substrates (Schoolnik et al., 1984; Virji & Heckels, 1984; Rothbard et al., 1985). While 
this possibility still exists, recent studies provide evidence for different adherence properties of 
the pili. At least three distinct adherence specificities, one for epithelial cells, one for 
erythrocytes and one allowing intergonococcal adherence, can be distinguished, either 
genetically or otherwise (Rudel et al., 1992). This does not exclude the association of pili with 
yet other adherence properties, such as for endothelial, phagocytic and sperm cells. 
Furthermore, N. meningitidis can produce two different classes of major subunit, class I and 
class II pilins, which may affect the adherence properties (Virji et al., 1989; 1992a). Pilin can 
be modified by phosphorylation and /or glycosylation (Robertson et al., 1977; Schoolnik et al., 
1984; Virji et al., 1993b), and it has recently been shown that the variant-dependent 
glycosylation of gonococcal pilin can influence receptor recognition (Virji et al., 1993b). 
However, the observed effect of pilin variation on adherence may be indirect and does not 
preclude a role for potential minor subunits in adherence.  
Indeed, recent studies suggest an association of minor protein components with the gonococcal 
pilus (Muir et al., 1988; Parge et al., 1990). One of these components, the PilC protein, has 
been characterized genetically and implicated in the biogenesis of pili (Jonsson et al., 1991), in 
epithelial cell adherence (Rudel et al., 1992) and transformation competence (Rudel et al., 
1995). Type IV pili also, mediate neisserial motility: twitching motility and social gliding 
motility, modes of migration along liquid-solid or liquid-air interfaces, implicated in a wide 
array of biological processes (Wall & Kaiser, 1999; Pujol et al., 1999; Merz & So, 2000). 
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Nonetheless, pili can be assembled in the absence of either of the two known PilC1 and PilC2 
proteins, probably by utilizing an alternative PilC-like assembly factor (Rudel et al., 1992). 
Moreover, the pili of pathogenic Neisseria species, irrespective of their structural variability, 
recognize the same, or a closely related, group of receptors. The first receptor for neisserial 
pili, CD46, was identified only recently (Källström et al., 1997). CD46, or membrane cofactor 
protein (MCP), is a member of the superfamily of complement resistance proteins. At least six 
CD46 splice variants have been identified, and CD46 variants are expressed on nearly all 
human cells except erythrocytes.  
The second major class of neisserial adhesins, the Opaque (Opa) proteins (previously referred 
to as class V proteins of the meningococcus and P.II proteins of the gonococcus), is encoded 
by the multigene opa family. N. gonorrhoeae strains typically harbour 11 opa loci, whereas N. 
menigitidis strains have 4-5 opa loci (Dehio et al., 1998). Specific opa repertoires vary from 
strain to strain. In contrast to the pilE genes, the genes encoding Opa proteins represent 
complete, rather than incomplete, variant genes (Stern et al., 1986; Jonsson et al., 1991) which 
undergo frequent phase transitions (on/off switches) but rarely recombine with each other 
(Connell et al., 1988; Bhat et al., 1991). These switches occur via a DNA slippage mechanism 
involving homo- or heteropolymeric repeated nucleotide sequences within the coding 
sequences of the genes (Connell et al., 1988; Robertson & Meyer, 1992); variation of the 
number of the repeating units alters the reading frame and consequently affects the translation 
into functional gene products. In case of the opa genes, the repeating unit is a pentameric 
(CTCTT) sequence.  
The role of Opa proteins in various adherence functions, such as interbacterial adhesion and 
interaction with human epithelial and phagocytic cells, has long been recognized (King & 
Swanson, 1978; Lambden et al., 1979; Virji & Heckels, 1986; Fisher & Rest, 1988; Makino et 
al., 1991; Belland et al., 1992; Virji et al., 1993a). Recent works suggest that Opa proteins not 
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only cause bacterial adherence but also trigger important cellular functions: the epithelial cell 
invasion (Virji et al., 1993a) and polymorphonuclear cells (PMNs) stimulation (Kirchner et al., 
2005). 
The Opa protein-host cell interaction seem to be a two step event, a weak and reversible 
attachment conferred by most of the Opa proteins and a tight probably receptor-specific 
interaction, this latter form appears to be a prerequisite for entry into host cells (Bessen & 
Gotschlich, 1986; Makino et al., 1991). A number of signalling molecules serve as receptors 
for various Opa proteins. The binding of Opa variants to their cognate receptors initiates 
different signalling cascades, leading to entry of bacteria vie distinct pathways, possibly also to 
different intracellular fates and/or infection outcomes. The first class of Opa receptors is 
heparan sulphate proteoglycans (HSPGs), which bind a subset of Opa variants that have 
surface-exposed loops rich in positively charged amino acyl residues (Chen & Gotschlich, 
1996; van Putten & Paul, 1995; Virji et al., 1999). Opa-HSPG interactions are not sufficient to 
promote internalization in epithelial cells; thus the possibility remains that Opa-HSPG 
interactions mediate only non-specific adhesion and that porins or other molecules then trigger 
lipid hydrolysis and bacterial uptake (van Putten et al., 1998a). Recent work from several 
groups has shown that many different Opas bind to members of the large CD66-related family 
of proteins. Different CD66 family members are variably expressed on different cell types. 
Depending on the particular CD66 variant and Opa protein expressed, different host cell 
responses occur, including binding, uptake, and the activation of different signal transduction 
pathways (Bos et al., 1997; Chen & Gotschlich, 1996; Chen et al., 1997; Gray-Owen et al., 
1997a, b; Hauck et al., 1998; Virji et al., 1996 a, b, 1999; Wang et al., 1998).  
The pathogenic Neisseriae often carries a copy of the phase variable opc gene whose product 
has a function similar to the epithelial cell-specific Opa proteins (Virji et al., 1992b). It is thus 
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evident that the variable Opa and Opc adhesions represent important cell tropism determinants 
of Neisseria spp and that the variability of these proteins allows multiple cellular interactions. 
The Neisseria species produce a short type of lipopolysaccharide (LPS) which lacks any 
repetitive O-side chains. Nonetheless LPS preparations from in vitro cultured bacteria reveal 
multiple size classes indicating a structural heterogeneity of the neisserial LPS (Schneider et 
al., 1988). Several lines of evidence suggest that LPS variation also occurs in vivo. In 
meningococcal carriers, the majority (70%) of bacteria isolated from the nasopharynx are 
unencapsulated and preferentially express a short LPS species (Broome, 1986), whereas in the 
diseased state, 97% of the blood and CSF isolates are encapsulated and of the long LPS species 
(Jones et al., 1992). A major difference among the variant LPS molecules is the presence of 
additional carbohydrate residues in the longer LPS forms that can be externally modified by a 
membrane-associated bacterial sialyltransferase using host-derived or endogenous 
cytidinemonophosphate-N-acetylneuraminic acid (CMP-NANA) as sialyl donor (Smith,1991; 
Mandrell & Apicella, 1993; van Putten, 1993). The functional relevance of the LPS phase 
transition has recently been elucidated and appears to lie in the expression of variable amounts 
of sialic acid incorporated in the different forms of LPS. A low sialylation phenotype, as found 
early in the infection, enables entry of the bacteria into mucosal cells, but makes them 
susceptible to bactericidal activity. In contrast, highly sialylated bacteria are incapable of 
entering epithelial cells but are resistant to phagocytosis and killing by antibodies and 
complement, allowing persistence of infection. Thus depending on the degree of sialylation the 
bacteria are either adapted to the extracellular environment and are capable of resisting 
humoral immune mechanisms, or they become sensitive to bactericidal activities but then 
readily enter the intracellular milieu via Opa-mediated cellular interaction (van Putten, 1993; 
Schneider et al., 1991). 
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The function of highly sialylated LPS has many similarities with that of polysialic capsules 
produced by N. meningitidis and many commensal Neisseria species, in that they protect 
extracellular bacteria against both specific and non-specific host responses (Frosch et al., 
1989).  
The polysaccharide capsule is the major pathogenicity factor of meningococci. Capsule 
expression is dependent on the possession and expression of the genes for capsule biosynthesis, 
modification, and transport, which are located in the regions A, B, and C, respectively of the 
cps locus of the meningococcal genome (Frosch et al., 1989) (Fig.4). The genes in region A 
determine the biochemical composition of the capsule and hence the serogroup (Edwards et al., 
1994; Claus et al., 1997; Swartley et al., 1997). In meningococci expressing capsules 
containing sialic acid (those corresponding to serogroups B, C, W-135, and Y), the region A 
comprises the genes siaA, siaB, and siaC, which are necessary for the synthesis of activated 
sialic acid (CMP-Neu5Ac), and the serogroup-specific gene siaD encoding the 
polysialyltransferase. In vitro studies have shown that slipped strand mispairing, as the 
reversible +1/-1 frameshift mutation within a poly (dC) repeat (Lavitola et al., 1999), and 
insertions into this region of the mobile element IS1301 account for reversible inactivation of 
the serogroup B capsule expression (Hammerschmidt et al., 1996a,b) which may favour 
colonization of the nasopharynx. Although phase variation of capsule expression has been 
observed, this structure appears to be primarily regulated by environmental factors (Brener et 
al., 1981). Loss of capsule expression favours an Opa and Opc-mediated interaction of N. 
meningitidis with target cells and thus seems to be a prerequisite for the cellular invasion (Virji 
et al., 1993a). The importance of the role of capsule in pathogenesis and as a vaccine 
component has stimulated interest in understanding the genetic mechanisms for regulation of 
its expression in the human host. Therefore, recent advances made in the analysis of capsular 
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(cps) gene organization and functions are important for understanding of the conditions 
favouring invasive meningococcal infection. 
The porins, abundant proteins of the outer membrane, form anion-selective ions channels that 
are essential for neisserial viability (Barlow et al., 1989; Gotschlich et al., 1987; Murakami et 
al., 1989; Suker et al., 1994). The functions of porins in colonization remain unclear but over 
the last 20 years several findings have suggested that these proteins exert a pivotal influence on 
the outcome of host-bacterial interactions. Some evidences indicates that porins (PorA and 
PorB) are capable of translocating into host cell membranes as active, gated ion channels, 
favouring the host cell invasion  (Lynch et al., 1984; Mauro et al., 1988, Mietzner et al., 1987; 
Rudel et al., 1996). It interferes with cell signalling, inducing a transient membrane 
hyperpolarization, inhibition of phosphatidylcholine-phospholipase C activity and failure of the 
NADPH oxidase function (Haines et al., 1988; Haines et al., 1991; Lorenzen et al., 2000). 
 
 
 
 
Figure 4. Schematic depiction of the capsule locus cps of N. meningitidis 
The genes for capsule biosynthesis, modification, and transport are located in the regions A, B, 
and C, respectively of the cps locus of the meningococcal genome. The genes in region A 
determine the biochemical composition of the capsule. In meningococci expressing capsules 
containing sialic acid, the region A comprises the genes siaA, siaB, and siaC, which are 
necessary for the synthesis of activated sialic acid, and the serogroup-specific gene siaD 
encoding the polysialyltransferase. 
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A common feature of pathogenic Neisseriae is the production and secretion of an antigenically 
diverse family of endoproteinases specifically affecting immunoglobulin A1 (IgA1) of their 
human hosts (Plaut et al., 1975). Like the closely related enzymes produced by Haemophilus 
influenzae these IgA proteases belong to the class of serine proteases (Bachovchin et al., 1990). 
Unlike the pilus and Opa proteins, IgA proteases are encoded by single copies of iga genes. 
Horizontal exchange of iga sequences resulted in numerous serologically distinct IgA proteases 
in N. gonorrhoeae and N. meningitidis (Halter et al., 1989; Lomholt et al., 1992; Morelli et al., 
1994). Despite this sequence variability the key features of the iga genes and gene products are 
conserved (Halter et al., 1989). Recent works have shown that the IgA proteases cleave Lamp1 
(lysosome-associated membrane protein), abundant transmembrane glycoprotein of 
mammalian lysosomes, favouring the survival of bacteria in the epithelial cells (Lin et al., 
1997; Ayala et al., 1998). 
As for most other pathogens, the molecular basis of infectious process events is a current topic 
in Neisseria research. Several evidences indicate that the initial attachment of Neisseria to 
mucosal cells may be followed by ingestion of attached organisms when the appropriate 
phenotype is present. Morphologically, this process involves an elongation of the microvilli 
and, in order to encompass the bacteria, the formation of zones of intimate contact between the 
bacterial and host cell membranes, along with engulfment of the bacteria via a zipper-like 
mechanism (Watt  & Ward, 1980; Tjia et al., 1988; Well & van Putten, 1988; Well et al., 
1991a, b; Stephens, 1989). It has been speculated that the insertion of the major neisserial ion 
channel protein I (porins) into host cells is a critical determinant for entry (Blake, 1985; Well 
& van Putten, 1991; Well et al., 1991b). Immunomorphological evidence supports binding to, 
or insertion, the proteins into the host cell membrane at the sites of bacterial entry during 
infection (Well & van Putten, 1991; Well et al., 1991b). Complete internalization of the 
bacteria requires phosphorilation of host proteins at tyrosine residues, but whether Opa protein, 
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porins, and other bacterial factors trigger this event is unclear (Grassmé et al., 1996). In all 
cases, it should be emphasized that these observations may be unique to the infection system 
and bacterial strain used, and may not represent uniform mechanisms or reflect the in vivo 
situation.  
Neisserial colonization of the human mucosa may give rise to an inflammatory response with 
recruitment and activation of professional phagocytes and activation of the host immune 
defence. Morphological data suggest that, in natural infection, the pathogenic Neisseria may 
reside inside phagocytes (Ward et al., 1972; DeVoe et al., 1973; Swanson & Zeligs, 1974). 
Dissection of the immunoresistant phenotype indicates that the bacteria possess a variety of 
antiphagocytic properties as well as a large repertoire of mechanisms that potentially allows 
them to be facultative intracellular microorganisms. An important step in Neisseria phagocyte 
interaction appears to be the distinct Opa protein-associated contact with the cells which results 
in induction of a respiratory burst and which may be followed by ingestion of the bacteria 
(King & Swanson, 1978; Rest et al., 1982; Virji & Heckels, 1986; Fisher & Rest, 1988; 
Belland et al., 1992).  
Once ingested, the bacteria probably reside in phagosomes and are exposed to the extremely 
hostile environment of oxidative and nonoxidative killing mechanisms, unless phagolysosomal 
fusion is inhibited, as may occur by the insertion of the bacterial ion channel in the vesicle 
membrane (Well et al., 1991b; Well & van Putten, 1991). The bacteria may counter the 
oxidative killing by increased oxygen consumption (Krieger et al., 1980; Cohen & Cooney, 
1984; Britigan et al., 1988), the production of high levels of catalase (Archibald & Duong, 
1986; Johnson et al., 1993) and by switching to anaerobic growth using nitrite as a source of 
energy (Hassett & Cohen, 1989). In addition, expression of a long LPS type and intracellular 
bacteriostasis may promote resistance to nonoxidative antimicrobial agents either by 
preventing the binding of cathepsin or antimicrobial cationic proteins to the bacterial penicillin 
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binding protein or inhibiting their detrimental effect, which requires active cell wall synthesis 
(Daly et al., 1982; Casey et al., 1985; Rock & Rest, 1988; Shafer; 1988; Shafer et al., 1990). In 
this way, the nongrowing bacteria may survive for prolonged periods awaiting cytotoxic lysis 
or exocytotic release from the cells perhaps as clumps of multiplying bacteria enclosed in host 
cell remnants. These so-called infectious units have been proposed to play an important role in 
the persistence and transfer of neisserial infection (Novotny et al., 1977).   
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EVOLUTIONARY CONTEXT AND HORIZONTAL EXCHANGE 
BETWEEN NEISSERIA SPP 
 
A series of recent studies emphasized the significance of horizontal genetic exchange in the 
evolution and epidemiology of Neisseria species. It appears that a continuous horizontal flow 
of genetic material affects the chromosomal composition not only of the pathogenic Neisseria 
species, but also of many commensal species (Halter et al., 1989; Manning et al., 1991; 
Feavers et al., 1992; Spratt et al., 1992; Zhou & Spratt, 1992). It is difficult to give precise 
estimates of the frequencies with which such horizontal exchanges occur in nature, however, in 
a few cases it is plausible that such events may have happened in recent years (Achtman, 
1994). Conceivably, horizontal genetic exchange can be envisioned as a long-term adaptive 
mechanism suitable for responding to gross environmental changes and for securing the 
genetic flexibility of Neisseria species. 
Smith and colleagues (Smith et al., 1991) proposed, based on gene linkage disequilibrium 
measurements, a significant difference in the clonal structures of N. meningitidis vs. other 
clonal species, such as Salmonella and Escherichia coli. The authors define several types of 
population structures, an entirely clonal structure, the epidemic structure and, at the other 
extreme, the panmictic structure with no evidence of linkage disequilibrium. These population 
structures are the result of two competing genetic processes, the genetic drift (mutagenesis) 
occurring within the scope of a species, and horizontal exchange (recombination) affecting this 
species extrinsically. Salmonella is little influenced by horizontal exchange and thus appears as 
a clonal population. Contrastingly N. gonorrhoeae constitutes a panmictic population in which 
horizontal exchange is overwhelming (O’Rourke & Stevens, 1994). N. meningitidis occupies 
an intermediate position in which occasional clonal outgrowths occurs in an otherwise 
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panmictic context. The latter population structure could be termed a “clonal network” 
comprising both sexual and clonal elements.  
The striking contrast between the strict clonality of Salmonella and E. coli and the clonal 
network structure of Neisseria appears to be reflected by distinct differences in the 
chromosomal organization of the genes of these species. The E. coli chromosome exhibits a 
considerable degree of organization concerning, for example, the linkage of related genes, the 
presence of operons and the transcriptional orientation of genes. Such a high degree of 
genomic organization is not seen in Neisseria, in which many functionally related genes (i.e., 
pil and opa genes) are distributed over the genome. Also, transcriptional coupling of genes 
(i.e., operons) is rarely found in Neisseria, although a few exceptions exist, including the 
tightly organized cps capsular gene cluster of the meningococcus (Frosch et al., 1989). Another 
remarkable phenomenon of Neisseria is the occurrence of multiple gene copies (gene families) 
which usually contain significantly diverse sequences. Whether the distinct chromosomal 
organization of Neisseria species is causally related to other unique features of these 
microorganisms, including the natural transformation competence, intra-strain variability and 
the population structures, is not well understood. Above all, it is unknown whether the genetic 
plasticity found in Neisseria species is related to the life style of these organisms, characterized 
by an extremely narrow host range and the ability to cause persistent infections, or whether it 
simply reflects the fact that these bacteria are young in evolutionary terms and still at the 
beginning of a long-term adaptative process with regard to their host. 
The ability of Neisseria spp to undergo DNA transformation under natural conditions was 
recognized some 30 years ago (Catlin & Cunningham, 1961; Sparling, 1966). Natural 
transformation competence differs markedly from the artificial transformation used for the 
cloning of genes, for example, in E. coli. In Neisseria the transforming DNA is taken up as a 
linear molecule and requires the RecA function and homologous sequences in the resident 
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DNA of the recipient cell in order to allow recircularization of a plasmid or incorporation of 
the DNA into the chromosome (Biswas et al., 1986; Koomey et al., 1987). The DNA 
homology requirement is probably the most effective mechanism of protection against bacterial 
transformation with unrelated DNA. Whether there is any role for the abundant DNA 
restriction and methylation systems of Neisseria species (Sullivan & Saunders, 1989; Gunn et 
al., 1992; Gunn & Stein, 1993) on transformation is currently not well understood. In addition 
to these restrictions, the Neisseria species recognize a specific DNA sequence, 8 bp in length 
that serves as a signal for the efficient uptake of DNA (Goodman & Scocca, 1988). 
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HYPERMUTATION IN PATHOGENIC BACTERIA: STRATEGIES 
FOR RAPID MICROENVIRONMENTAL ADAPTATION 
 
Microbial populations not only need to adapt to the gross long-term environmental changes 
encountered during co-evolution with the host but, in addition, encounter frequent usually 
recurrent microenvironmental changes, for example, during the course of an infection. In order 
to respond to such recurrent changes, microorganisms maintain retrievable genetic programs. 
There are two principle types of adaptive programs used by microorganisms: (1) Genetic 
variation concerns spontaneous changes in the DNA which are inherited to the progeny and are 
often reversible. These changes, although temporally random, take place at spatially distinct 
loci and ultimately lead to the synthesis of altered gene products. As a consequence, genetic 
variation generates heterogeneous population of a distinct microbial strain, such that a fraction 
of this population is likely to show an improved microenvironmental adaptation. (2) By 
contrast, the second microbial adaptation strategy, gene regulation, influences the bacterial 
population as a whole. In response to a certain environmental stimulus, such as temperature, 
osmolarity, or specific substances, the bacteria alter the expression of responsive genes in a 
coordinated fashion. Stress responsive systems sensitive to heat shock and/or other stress 
conditions, such as nutrient starvation and iron limitation, have been identified. The genetics of 
some of these systems is currently being studied (Taha et al., 1988; Fyfe et al., 1993).  
Obviously both strategies have specific advantages for microorganisms: while genetic variation 
better protects minor parts of the population against a large variety of unpredictable changes, 
gene regulation affects a well-determined adaptive process for the benefit of the whole 
population. However, genetic variation and gene regulation are not exclusive and are often 
interconnected. Likewise, the frequency and the direction of a switch may be influenced by 
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environmental effectors, and conversely, a phase-variable regulator protein may control the 
expression of genes (Robertson & Meyer, 1992). 
Several works indicate that the genes coding for virulence determinants, in N. meningitidis and 
many so-called pathogenic bacteria such as Haemophilus influenzae, Staphylococcus aureus 
and Streptococcus pneumoniae, must evolve in response to the demands (selection pressures). 
N. meningitidis, like other commensal bacteria, must surmount a variety of environmental 
hurdles to successfully colonize a genetically and immunologically diverse host population, 
evade the constitutive and inducible defences of these hosts and be transmitted to new hosts. 
To meet these challenges, these bacteria have highly mutable “contingency” genes (Moxon et 
al., 1994; Bayliss & Moxon 2002), which code over 100 surface-associated components, 
including capsule, type IV pili, and surface sugar biosyntesis proteins involved in 
lipooligosaccharide metabolism and outer membrane proteins acting as porins, adhesins, or 
invasins or involved in iron uptake (Moxon et al., 1994; Snyder et al., 2001). Mutations in 
these genes, coding for molecules needed for colonization and persistence in human hosts and 
transmission to new hosts, generate variation and ensure that at least a fraction of a bacterial 
population expresses a phenotype that is compatible with a productive infection cycle 
(Hammerschmidt et al., 1996; de Vries et al., 1996). 
In the case of N. meningitidis, contingency genes are turned on and off by a mutational 
mechanism called phase shifting (or phase variation) that increases the rate at which these 
genes mutate to different states, including states that may be detrimental to the bacterium. 
Depending on the strain, the N. meningitidis contains a different number of these contingency 
genes, each of which contains microsatellites (extended stretches of repeated nucleotide 
motifs) which are hot-spots for replication errors (Saunders et al., 2000). High rates of 
nucleotide addition and deletion occur in these regions, which may offset the codon reading 
frame and thereby transform the downstream sequence into non-sense or back into sense. The 
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rates of phase shifting vary among genes and among strains of N. meningitidis. For example, 
switching rates in receptors responsible for iron uptake have been measured to range from 2 X 
10-2 to 7 X 10-6 per c.f.u. (colony forming unit)  (Richardson & Stojiljkovic, 1999), which 
differ from the rates of phase variation found in other genes (Murphy et al., 1989; Jonnson et 
al., 1991; Hammerschmidt et al., 1996). Analysis of meningococcal strains from worldwide 
epidemics revealed frequent elevations in rates of phase shifting. This is consistent with the 
view that the demands of between-host colonization may favour high rates of phase shifting of 
genes associated with colonization. Approximately half of 100 serogroup A isolates sampled 
from the epidemics were found to be fast shifters (rates greater than 5 X 10-5 per c.f.u.), and 
estimates of this ratio continue to increase as more strains are analysed. Furthemore, the 
prevalence of fast shifters in this set of strains increases as the epidemic progresses in time 
(Richardson et al., 2002). One possible explanation is that, as the epidemic progresses, an 
increasing fraction of the population has acquired one or more antigenic variants of N. 
meningitidis. Subsequent infections of these individuals require changes in the antigenic state 
of the bacterium, such as those that could be generated by phase shifting. Probably, the rapid 
phase shifting is evolved and maintained by selection operating at an epidemiological level, as 
a mechanism to facilitate colonization and infectious transmission to new immunologically 
diverse hosts, increasing the likelihood that colonizing populations of N. meningitidis will 
cause invasive disease.  
Presumably, the virulence of N. meningitidis does not confer any long-term advantage to the 
bacteria in its ability to spread through a community of hosts (and may even be detrimental), 
but rather is an inadvertent consequence of mutation and selection within individual hosts. 
Levin and Bull have called this phenomenon the “short-sighted” evolution of virulence (Levin 
& Bull, 1994; Taha et al., 2002).  
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DNA RECOMBINATION AND REPAIR IN PROKARYOTES 
 
Most of our understanding about the processes of DNA recombination and repair in 
prokaryotes comes from studies on model organism Escherichia coli. Decades of biochemical 
and genetic investigation have produced a detailed knowledge of the molecular mechanisms 
underlying these basic processes of DNA metabolism, providing paradigms and milestones 
(Modrich, 1991; Kuzminov, 1999). In N. meningitidis, microorganism that is considered as a 
paradigm of genetic variation, several molecular processes are similar to E. coli, others appear 
to be divergent (Kline et al., 2003; Davidsen & Tonjum, 2006).  
The genetic basis for this variation depends on the evolution of iterative DNA motifs, 
especially homo-polymeric tracts, to effect reversible, high frequency molecular switching 
through slippage-like mechanisms. The variation in number of homo-polymeric repeats affects 
gene expression by transcriptional or translational mechanisms (Bayliss, et al., 2004). Although 
the mutation rate at homo-polymeric repeats is high in all strains, several strains isolated from 
patients may be hyper-mutable at these loci due in part to genetic defects in the DNA mismatch 
repair (MMR) process. Epidemic serogroup A isolates have elevated missense mutation rates 
and phase variation frequencies, which were caused by defects in MMR proteins, MutL and 
MutS in about 40% of the strains (Richardson et al., 2002). 
DNA mismatch repair, one of several DNA repair pathways conserved from bacteria to 
humans, plays a critical role as a guardian of the genome in virtually all cells. It contributes 
about 1000-fold to the overall fidelity of replication and targets mispaired bases that arise 
through replication errors, during homologous recombination, and as a result of DNA damage. 
In E. coli MMR recognizes base–base mismatches except C/C or small insertion/deletion 
nucleotide loops (IDLs) up to four nucleotides in length, which are intermediates in frameshift 
mutation, and probably also to sites of DNA damage (Mello et al., 1996). Mismatch 
recognition by MutS (homodimeric ATPase), in the presence of ATP, drives MutL (member of 
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the GHKL superfamily of ATPase) recruitment and subsequent activation of MutH, an 
endonuclease that recognizes hemi-methylated d(GATC) sequences, and cleaves the un-
methylated sites spanning the mismatch. The nick serves as a point of entry for Ssb (single-
stranded DNA binding protein) and halicase II (for example UvrD, MutU), whose loading at 
the nick is facilitated via protein-protein interactions with MutL. d(GATC) adenine methylase 
(Dam) plays a key role in this process, as during DNA replication only the parental strand is 
fully methylated and methylation of daughter strand is not immediate, allowing directionality 
to MMR (Modrich, 1989; 1991). Excision of the newly synthesized strand between the nick 
and the mismatch is carried out by one of four single-strand exonucleases: 3’-5’ exonucleases 
ExoI or ExoX, or 5’-3’ exonucleases RecJ or Exo VII (Viswanathan & Lovett, 1999; Burdett et 
al., 2001). DNA polymerase III, Ssb, and DNA ligase carry out repair synthesis (Fig.5).  
There are several important aspects that differentiate MMR in E. coli and N. meningitidis 
(Davidsen & Tonjum, 2006). These include: (i) lack of MutH endonuclease in all 
meningococci (Richardson et al., 2002); (ii) absence of Dam methylase in several 
meningococcal virulent lineages (Bucci et al., 1999; Jolley et al., 2004); (iii) lower spontaneous 
mutation rates in meningococcal MutS- or MutL-defective strains compared with MutY-
defective mutants (Richardson et al., 2001; 2002). In contrast, in E. coli MutS- or MutL-
defective mutants exhibit stronger mutator phenotypes than MutY-defective strains (Michaels 
et al., 1992). Clearly, mechanisms other than MMR are implicated in meningococcus mutator 
phenotypes, as alterations of the DNA glycosylase MutY involved in the base excision repair 
pathway and in the protection against oxidative stress (Davidsen et al., 2005).  Tuning down 
the level of activity of the MMR system, also in MMR-proficient strains, may be associated to 
natural competence of meningococci for transformation. The importance of natural 
transformation among mucosal pathogens is well established: it promotes horizontal exchange  
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Figure 5. The methyl-directed MMR system of E. coli 
Mismatches that arise during replication are recognized by dimeric MutS protein and 
hemimethylated dam sites are bound by MutH. Binding of ATP mediates formation of the 
ternary complex heteroduplex DNA-MutS-MutL, and ATP hydrolysis activation of MutH, 
which incises the newly synthesized and transiently unmethylated strand. Further steps include 
DNA unwinding by helicase II from the site of the nick followed by degradation of the single 
strand by one of several partially redundant 5’-3’ exonucleases or 3’-5’ exonucleases. The 
single-stranded template strand is protected by Ssb. Resynthesis is performed by polymerase 
III and the remaining nick is sealed by ligase. 
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of genetic material among Neisseria, responsible for the mosaic nature of virulence factors and 
housekeeping genes (Alexander et al., 2004; Davidsen & Tonjum, 2006).  
Mismatch repair also is known to be a barrier to interspecies recombination. Indeed, MutS, 
MutL and MutH play a role in blocking DNA recombination between partially divergent 
sequences, known as homeologous recombination. For example, interspecies gene transfer 
between Salmonella and E. coli is normally repressed but becomes unrestrained when 
mismatch repair proteins, MutS and MutL in particular, are absent. Prevention of 
recombination between divergent sequences ensures the stability of the genome and individual 
species (Matic et al., 1996; Stambuk & Radman, 199; Harfe & Jinks-Robertson, 2000). 
In N. meningitidis, the antigenic variation of several virulence determinants allows the 
optimization of adhesion and invasion processes by finely tuning intermolecular interactions 
with the available host receptors, and, at a later stage, to escape the immune response 
(Robertson & Meyer, 1992). Antigenic variation involves both homologous recombination 
activities and specific factors (Wainwright et al., 1994; 1997).  
Homologous recombination is described in detail in E. coli, where genetic studies are 
delineated two recombinational pathways; the primary, RecBCD pathway, serving the needs of 
“sexsual” recombination, and the secondary, RecF pathway, kicking in when the primary 
pathway is inactive and moonlighting  at “postreplication repair” of daughter strand gaps 
(Clark, 1973; 1988; Clark & Sandler, 1994).  Biochemical characterization of recombinational 
activities suggested that their primary role is in DNA repair (Cox, 1991; 1993).  
Genes from both of these pathways have been found in Neisseria and have been shown to have 
a role in DNA recombination and repair mechanisms. RecA and the RecF-like pathway (RecO-
, RecQ- and RecJ-dependent) of recombination, as well as RecX and Rep helicase, are essential 
for pilin antigenic variation (Koomey et al., 1987; Mehr & Seifert, 1998). In contrast, 
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recombination during transformation partially requires the activity of the RecBCD pathway in 
addition to RecN, RecX and Rep (Salvatore et al., 2002; Kline & Seifert, 2005).  
Important aspects that differentiate recombination pathways in E. coli and N. meningitidis are: 
(i) lack of an SOS response in meningococci; (ii) absence of a RecF homologue, although 
RecF family members do exist in this species (Kline & Seifert, 2005; Davidsen & Tonjum, 
2006).  
Interestingly, there is recent evidence that antigenic variation rates may differ in various 
clinical isolates as a consequence of genetic defects in DNA recombination pathways (Bucci et 
al., 1999; Richardson & Stojiljkovic, 2001; Salvatore et al., 2002). Serogroup B and serogroup 
C meningococci belonging to the ET-37 lineage harbouring the non-functional recBET-37 allele 
were defective both in repair of DNA lesions induced by UV treatment, and, partially, in 
recombination mediated transformation. The recBET-37 allele considerably increased the 
frequency of antigenic variation at the pilin loci (Salvatore et al., 2002), leading to the 
hypothesis that the RecBCD nuclease may compete with the RecF-like pathway for 
recombination intermediates of pilin gene conversion (Salvatore et al., 2002; Kline et al., 
2003).  
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AIM OF THE STUDY 
Reports from recent studies suggest that genetic lesions in DNA repair pathways may occur in 
natural bacterial populations. The occurrence of defective alleles of DNA repair and 
recombination genes is the rule, not an exception, in microorganisms. These alleles, or possibly 
their combination, play an important role in the long-term evolution of pathogenic traits. They 
affect the general mutability and/or the frequency of genetic exchanges. They also influence by 
more specialized mechanisms of genetic (phase and antigenic) variation short-term adaptation, 
even within a single infection cycle, of pathogenic microorganisms to their specific hosts. The 
cost of a reduced individual fitness, which is invariably associated to genetic lesions in DNA 
repair and recombination systems, is balanced by these extra benefits. 
In this study we discovered a moderate mutator phenotype in several serogroup B invasive 
strains of N. meningitidis, phylogenetically related to the lineage III. The lineage III strains 
made their appearance in 1980, starting homogeneously with regard to both genotype (ET-24; 
ST-44) and phenotype (B:4:P1.4). After 1984, other clones appeared in the lineage, and the 
various clones acquired other serotypes (serotypes 14 and 15) and subtypes (P1.2, P1.7, and 
P1.12), indicating frequent exchange of genetic material between clones. In this study the 
mutator phenotype in the lineage III strains was associated to the presence of defective mutL or 
mutS alleles that were genetically characterized. In addition, we have found a novel link 
between the mismatch repair and the RecBCD recombination pathways. 
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MATERIALS AND METHODS 
Bacterial strains and growth conditions 
 
Meningococcal invasive strains used in this study are listed in Table 2. Serotypes, sero-
subtypes and assignment of the strains to hypervirulent lineages are shown in the table. The 
eight meningococcal strains phylogenetically related to the lineage III (ET-24) were isolated 
during outbreaks of epidemic disease, which have occurred in different places of Italy and 
France during the last 20 years. BL892 conserved the same serotype and subtype (B:4:P1.4) as 
the original lineage III strains isolated in 1980 (Scholten et al., 1994). The other strains 
acquired other serotypes and subtypes (serotype 1 in BL942; subtypes P1.1 in BL951, and 
P1.13 in an epidemic clone including five strains, BL851, BL859, BS843, BS845 and BS849) 
or were not serotypable or subtypable. The eight strains were indistinguishable by comparing 
restriction fragment length polymorphysm (RFLP) patterns in eight housekeeping genes, and, 
therefore, they were all assigned to the same genetic lineage (Salvatore et al., 2001).  
All meningococcal strains were cultured on chocolate  agar (Becton-Dickinson) or on GC-agar 
or broth supplemented with 1% (v/v) Polyvitox (Bio-Merieux) at 37 °C in 5% CO2. 
 E. coli strain DH5α was used in cloning procedures. Luria-Bertani (LB) was used as a growth 
medium. When requested, LB was supplemented with ampicillin (100 μg ml−1). 
 
DNA procedures 
 
High molecular weight genomic DNA from the different N. meningitidis strains was prepared 
as previously described (Bucci et al., 1999). DNA fragments were isolated through acrylamide 
slab gels and recovered by electroelution as described (Sambrook et al., 2001). Coding regions 
 43
of the genes mutS and mutL were amplified from chromosomal DNA by using PCR with the 
primer pairs mutS1–mutS2 and mutL1–mutL2 (Table 1), respectively. The oligonucleotide pair 
mutL1Sal5/37–mutL2Bam (Table 1) was used to provide the mutL-coding sequences with 
flanking SalI and BamHI restriction sites for cloning strategies. The amplification reactions 
consisted of 30 cycles including 1 min of denaturation at 94 °C, 1 min of annealing at 55 °C 
and 1–2 min of extension at 72 °C. They were carried out in a Perkin-Elmer Cetus DNA 
Thermal Cycler 480. Labeling of the DNA fragments to be used as probes in Southern blot 
experiments was performed using standard protocols (Sambrook et al., 2001). The nucleotide 
sequences of the amplified coding region of mutS and mutL were determined by the dideoxy 
chain termination procedure using, as primers, the following oligonuleotides (Table 1): mutS1, 
mutS2, mutS3, mutS4, mutS5, mutS6, mutS8, mutS9, mutS10, mutS11, mutSIS1 and mutSIS2 
(for mutS); mutL1, mutL2, mutL3, mutL4 and mutL5 (for mutL). DNA sequencing was 
performed as a service by CEINGE Biotecnologie Avanzate s.c.a.r.l., Napoli (Italy). Deduced 
amino acid sequence similarity searching was performed with the BLAST program using the 
conserved domain database (CDD) available at the National Center for Biotechnology 
Information (NCBI). Prediction of coiled coils from protein sequences was obtained using the 
Lupas algorithm (Lupas et al., 1991) available at the Pôle Bioinformatique Lyonnais (PBIL).  
 
Plasmids, cloning procedures and transformation of meningococci 
 
A 4548 bp-long SalI DNA fragment derived from pNMRecBET-37 (Salvatore et al., 2002), 
spanning the entire coding region of recBET-37, was used to transform the UV-resistant strain 
BL892. UV-sensitive transformants were isolated with a frequency of about 0.5%.  
Replacement of recBET-37 for the wild-type recB allele was verified by Southern blot analysis as 
previously described (Salvatore et al., 2002). To construct pDE-MutLET-5, the DNA  
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Table 1. Oligonucleotides used in this study 
 
Name Sequence 
mutL1 5’- GGTATTTTCCAAACGGGATAAACGGC-3’ 
mutL2 5’-TCAAAGTCAGTTTGACCCAAGTCGG-3’ 
mutL3 5’-CAATACTGCTTCGTCAACCATCG-3’ 
mutL4 5’-AAGCGGATTTCGGTTTTGGTCG-3’ 
mutL5 5’-TCGTGATGTTTCTGTCGGTGCG-3’ 
mutL1Sal5/37 5’-GGAAGCGTCGACTATGTCCCGAATCGCCGCCCTGCC-3’ 
mutL2Bam 5’-TATTCT GGATCCTTTCGGCTTACTGTCCGCGCAAG-3’ 
mutS1 5’-AAATCCGCCGTTTCCCCAATGATGC-3’ 
mutS2 5’-TACAGTTCTGACAATGCTTCGCGC-3’ 
mutS3 5’-CTCGAAACCGACAGCCAATATATCG-3’ 
mutS4 5’-CAAAACCAAGCTGACAACTGTGG-3’ 
mutS5 5’-TGGATTTGGAAGCCAAGGAACGC-3’ 
mutS6 5’-TAGGTCAGCTCGAAATAGTGGG-3’ 
mutS8 5’-TAACACCCGATGCCGTCTGAAGTTG-3’ 
mutS9 5’-AATATGGGCGGCAAATCCACCTAC-3’ 
mutS10 5’-GGTTGGATTTGGTGCAGGAAAACG-3’ 
mutS11 5’-AAACGGCACGCCTGCCATTTTGAC-3’ 
mutSIS1 5’-TTGCGCACTCACTTTAATCAGTCCG-3’ 
mutSIS2 5’-CGAATTGCTGGAACTGATCAACCG-3’ 
recB1Hind 5’-GCAACAAGCTTCCGGCTGCAACTGGATTTAATCG-3’ 
recB2Hind 5’-GGCGGCAAGCTTTTCGAGCAGTTGGAAATAATTGG-3’ 
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corresponding to the entire mutL-coding region was amplified from the genome of MC58 (ET-
5) using primers mutL1Sal 5/37 and mutL2Bam. 
The SalI–BamHI-restricted 1991 bp PCR product was cloned into the SalI–BamHI-restricted 
pDEX vector plasmid (Pagliarulo et al., 2004). To obtain pDEΔ-RecB, the central coding 
region of recB from MC58 was amplified using the primer pair recB1Hind/recB2Hind. Then, 
the HindIII-restricted 1101 bp PCR product was cloned into HindIII-restricted pDEX.  
Transformation of meningococci was performed as previously described (Salvatore et al., 
2002) by using 0.1–1 μg of plasmids or DNA fragments. Transformants were selected on GC-
agar medium containing erythromycin (7 μg ml−1) when requested. 
 
UV survival assays  
 
 
Meningococcal cells were grown to late logarithmic phase in GC medium supplemented with 
Polyvitox. When the cultures reached an optical density at 550nm (OD550nm) of 1.0, 10 μl of 
serial dilutions were spotted onto Petri dishes containing GC-agar plus Polyvitox supplement. 
Irradiation was achieved by opening the plates under a SpectrolineR model ENF-260C/F 
UV(254) germicidal lamp (Spectronics Corporation, Westbury, NY, USA) at a distance of 15 
cm for different times, in the absence of daylight illumination. As a control, dilutions from the 
same cultures were spotted onto non-irradiated plates. UV fluences were determined as 
described (Salvatore et al., 2002). Exposure to the germicidal lamp never resulted in an 
increase of temperature of the GC-agar medium more than 0.1 °C, as measured by platinum 
probe (Pt-RTD 100Ω) that was placed at the surface of the medium.  
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Determination of spontaneous mutation frequencies  
 
 
In these assays strains were grown in GC broth supplemented with 1% (v/v) Polyvitox (Bio-
Merieux) at 37 °C with shacking to late logarithmic phase (1.0 OD550nm), starting from single 
colonies grown over-night in GC-agar with 1% (v/v) Polyvitox at 37 °C in 5% CO2. For each 
strain, a total of 300 colonies were tested in 10 distinct experiments (30 colonies for each strain 
in each experiment). After growth, 1 ml cultures (about 1×109 colony forming units [cfu]) were 
plated onto selective GC-agar containing 36 μg ml−1 rifampicin (Sigma–Aldrich s.r.l.). Serial 
dilutions were treated in parallel and plated on GC-agar to determine the viable cfu. 
Rifampicin-resistant colonies were counted after 24 h incubation at 37 ◦C in 5% CO2. 
Mutation frequencies were calculated in each set of experiment by using the method of the 
median (Lea & Coulson, 1949) that was proved to be accurate for our purposes by preliminary 
experiments (Rosche & Foster, 2000). Values in Tables 2, 4 and 5 represent means of mutation 
frequencies (medians) to rifampicin-resistance obtained in each set of experiments. For 
statistical analysis a standard t-test (Zar, 1984) was used. Fluctuation is usual with the mutation 
rates seen for rifampicin-resistance so that only differences of a factor 2 or more were 
considered significant (Glickman & Radman, 1980). By using lower rifampicin concentration 
(9 μg ml−1) we did not observe substantial change in the relative mutability of the strains. 
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RESULTS 
 
 
Mutation frequencies to rifampicin-resistance in lineage III meningococcal strains 
 
 
 In Table 2 spontaneous mutation frequencies to rifampicin resistance were determined in the 
lineage III isolates and in several meningococcal strains belonging to the ET-5 and to the ET-
37 (serogroup B and C) hypervirulent lineages as detailed in Materials and Methods. The 
lineage III strains exhibited different mutation frequencies. When compared to the ET-5 strain 
MC58, the lineage III strains BL942 and BL892 exhibited, respectively, about 7.8- and 2.4-
fold higher mutation frequencies. A moderate mutator phenotype was also present in BL951 
(1.9-fold higher mutation frequencies than in MC58), but not in the epidemic clone including 
strains BL851, BL859, BS843, BS845 and BS849. In this assay, all tested ET-5 strains 
(BL899, BL937, BF23, BZ169, H44/76 and MC58) and most ET-37 strains (BF2, BF40 and 
NGP165) gave similar values, with the exclusion of the ET-37 strain 93/4286 that showed a 
clear mutator phenotype (7.7-fold higher mutation frequencies than in MC58). 
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 Table 2. Mutability to rifampicin-resistance of meningococcal clinical isolates 
 
Strain 
Serogroup 
and/or 
serotypea
Lineageb
Clinical 
specimenc
Mutation 
frequencyd per 109 
cells, median n° 
Sourcee
BL851 B:4:P1.13 ET-24 CSF 2.81 i. 
BL859 B:4:P1.13 ET-24 CSF 3.12 i. 
BS843 B:4:P1.13 ET-24 BL 2.79 i. 
BS845 B:4:P1.13 ET-24 BL 2.68 i. 
BS849 B:4:P1.13 ET-24 BL 3.20 i. 
BL892 B:4:P1.4 ET-24 CSF 5.67 ii. 
BL942 B:1:NST ET-24 CSF 18.75 ii. 
BL951 B:NT:P1.1 ET-24 CSF 4.46 ii. 
BL899 B:4:P1.2,5 ET-5 CSF 1.93 ii. 
BL937 B:4:NST ET-5 CSF 1.85 ii. 
BF23 B ET-5 NP 2.60 iii. 
BZ169 B ET-5 CSF/BL 2.47 iv. 
H44/76 B ET-5 CSF/BL 2.53 iv. 
MC58 B ET-5 CSF/BL 2.39 iv. 
BF2 B ET-37 NP 2.68 v. 
BF40 B ET-37 NP 2.52 iii. 
93/4286 C ET-37 CSF/BL 18.41 iv. 
NGP165 B ET-37 CSF/BL 1.92 iv. 
 
aNT, not serotypable; NST, not sub-serotypable. 
bThe assignment of the isolates to hypervirulent lineages has been determined as previously 
described (Salvatore et al., 2001). ET-24 or lineage III. 
cNP, nasopharynx; CSF, cerebro-spinal fluid; BL, blood. 
dData were obtained by 10 independent experiments. In each experiment, 30 independent 
cultures of each strain were tested. Values represent means of mutation frequencies (medians) 
to rifampicin resistance obtained by mutagenicity assay in each set of experiments. For each 
strain these values did not differ more than 20%. 
ei. Istituto Superiore di Sanità, Roma, Italy; ii. Institut Pasteur, Paris, France. iii. Hôpital 
d'Instruction des Armée, BREST NAVAL, France; iv. IRIS, Chiron S.p.A, Siena, Italy; v. 
Laboratory of Microbiology, Università di Napoli, Italy. 
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Nucleotide sequences of mutS in meningococcal strains  
 
As a mutator phenotype is frequently caused in meningococci by mutations in mismatch repair 
genes mutL and mutS (Richardson & Stojiljkovic, 2001) the nucleotide sequence of mutS was 
determined in the lineage III strains BL892, BL951 and BL942, and in the ET-37 strain 
93/4286. The alignment of the deduced amino acid sequences of the mutS genes from BL892 
and MC58 demonstrated a high degree of similarity (>98% identity). The 18 amino acid 
substitutions we found in the MutS protein of BL892 affected either synonymous (9 of 18) or 
non-conserved residues (9 of 18) on the basis of the available consensus for the MutS family 
proteins (COG0249 at the NCBI data base). Similarly, the MutS protein of BL951 exhibited 
only 15 amino acid substitutions compared to that of MC58. Twelve out of these fifteen 
substitutions were also found in the MutS protein of BL892, and the remaining three 
substitutions affected non-conserved residues. In contrast, the mutS allele from BL942 was 
functionally inactive as a consequence of a cytosine deletion at position 235 of the coding 
region responsible for shifting of the reading frame (Fig. 6). The mutS allele from 93/4286 was 
subjected to a different mechanism of inactivation: insertion of an IS1106 element (Salvatore et 
al., 2001), which targeted the sequence AGCCT at position 2146–2150 of the nucleotide 
sequence of the mutS coding region. This insertion was predicted to interrupt the ATPase 
domain of MutS (Fig. 6).  
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Figure 6. Insertional and frame-shift inactivation of mutS in meningococcal strains 
 
The genetic map of the mutS gene from the ET-37 strains FAM18 and 93/4286, and the lineage 
III strain BL942 is depicted in the upper part of the figure. The mutS gene from 93/4286 is 
interrupted by an IS1106 transposable element, while that from BL942 contains a frame-shift 
mutation (a deletion of one cytosine residue). The repeated sequences at the level of the 
insertion site are indicated. The functional domains of MutS protein are drawn below the 
genetic map. MutS I: domain corresponding to globular domain I in Thermus aquaticus MutS 
(Obmolova et al., 2000); MutS II: domain corresponding to globular RNAse-H-like domain II 
in T. aquaticus MutS; MutS IV: domain corresponding to globular domain IV in T. aquaticus 
MutS, which is involved in DNA binding; MutS V: domain corresponding to globular domain 
V in T. aquaticus MutS, which contains a Walker A motif, and is structurally similar to the 
ATPase domain of ABC transporters; MutSd: DNA-binding domain of MutS; MutSAc: 
ATPase domain of MutS. 
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Mutations of meningococcal  mutL allele in different virulent strains 
 
The alignment of the deduced amino acid sequence of the mutL genes from the lineage III 
strains with the available sequences from MC58 (ET-5), FAM18 (ET-37) and Z2491 (IV-I) 
revealed the presence of multiple amino acid substitutions differently distributed among the 
strains. Most of these substitutions coincided with those previously identified by Richardson 
and Stojiljkovic (Richardson & Stojiljkovic, 2001) in a meningococcal mutator mutL allele 
(Table 3). In particular, the highest number of amino acid substitutions (21 out of the 23 typical 
of the mutator allele) was detected in the mutL allele from BL942, the strain that also carried a 
functionally inactive mutS allele, and exhibited the strongest mutator phenotype (Table 2). In 
the mutL allele from BL892 (mutLBL892) the number of amino acid substitutions was lower (17) 
and even lower in the mutL alleles from BL851 and BL951 (11). The mutL alleles from MC58 
(ET-5), Z2491 (IV-I) and FAM18 (ET-37) exhibited, respectively, 11, 12 and only a single 
amino acid substitution. This result may be of relevance because the ET-37 strains, except 
93/4286, seem to be generally characterized by lower spontaneous mutability (Table 2) and 
lower ability to be transformed by exogenous DNA (Salvatore et al., 2002). The mutL allele 
from the mutator strain 93/4286 was almost identical to that from FAM18 (data not shown).  
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Table 3. Substitutions in the deduced amino acid sequences of MutL proteinsa 
 
 
 
 
 
 
 
aOnly substitutions that are typical of mutL mutator alleles (Richardson and Stojiljkovic, 2001) 
are indicated. bN513R; cV523I; dN580S. 
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mutL allelic replacement in the lineage III strain BL892 
 
To verify the causal association between genotype and mutator phenotype, the mutL gene in 
the BL892 chromosome was replaced by the homologous gene from MC58 using the linearized 
plasmid pDE-MutLET-5 (Fig. 7A). The allelic replacement by transformation and double cross-
over was verified by Southern blot by screening 96 recombinant strains (Fig. 7B). In only one 
strain, BL892 mutLET-5, mutL was almost entirely replaced. In this strain, as a result of the 
recombination event, two HinfI DNA fragments of the expected sizes (503 and 630 bp) were 
detected by mutL-specific probe (Fig. 7B, lane 3), in place of the about 2500 bp-long  HinfI 
fragment of the parental strain BL892 (Fig. 7B, lane 1).  
This result was confirmed by PCR restriction analysis (Fig. 7C) using a primer pair designed to 
amplify the entire mutL-coding region (Fig. 7A) followed by HinfI digestion. The restriction 
pattern of BL892 mutLET-5 (Fig. 7C, lane 4) was almost identical to that of MC58 (Fig. 7C, 
lane 2) with exception of the more distal 154 bp DNA fragment, specific of MC58, at the 
recombination site (Fig. 7A). The allelic replacement suppressed the mutator phenotype of 
BL892 resulting in mutator levels comparable to those observed in MC58 (Table 4). This 
finding demonstrated that the enhanced mutability of BL892 strain was the result of non- or 
less-functional mutL allele.  
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Figure 7.  mutL allelic replacement in BL892 
 
(A) Experimental design for mutL allelic replacement in BL892 generating BL892 mutLET-5 by 
double cross-over using linearized pDE-MutLET-5. Location of HinfI (Hf) restriction sites and 
distribution of missenses (bar) are reported. Positions of the DNA probe (black rectangle) used 
in Southern blot experiment (B) and of the primer pair (arrows) used in PCR-restriction 
analysis (C) is also indicated.  
(B) Southern blot analysis. Total DNAs derived from BL892 (lane 1), MC58 (lane 2) or BL892 
mutLET-5 (lane 3) were digested by HinfI and analyzed by Southern blot using the DNA probe 
indicated in (A). Relative migration of DNA molecular weight ladders is reported on the left. 
Arrowheads on the right indicate MC58-specific fragments. 
(C) PCR-restriction analysis. Total DNAs derived from MC58 (lane 2), BL892 (lane 3) or 
BL892 mutLET-5 (lane 4) were used as templates in PCR reaction with the primer pair (mutL1 
and mutL2Bam) above indicated (A). The PCR products were purified and digested by HinfI 
and analyzed by agarose gel. In lane 1 DNA molecular weight ladders were run in parallel, and 
their relative migration is reported on the left. The sizes of MC58- and BL892 mutLET-5-
specific fragments are indicated on the right. 
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Table 4. Effects of mutL allelic replacement or integration of plasmid pDE-MutLET-5 into 
the chromosome of BL892 on mutability to rifampicin-resistance 
 
 
Strain 
Spontaneous mutation frequencya
per 109 cells, median n° 
BL892 5.67 
BL892 mutLET-5 2.45 
BL892ΩmutLET-5-2 2.49 
BL892ΩmutLET-5-6 5.65 
BL892ΩmutLET-5-13 5.50 
BL892ΩmutLET-5-14 2.52 
BL892ΩmutLET-5-15 2.66 
 
aMutation frequencies to rifampicin resistance were determined as described in footnote to 
Table 2. 
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Cointegration assay in the mutL locus of BL892 
 
The result of allelic replacement was further supported by mutagenicity assays in cointegrant 
strains. To this purpose, plasmid pDE-MutLET-5, harbouring a promoter-less mutL allele from 
MC58 was used to generate cointegrates with the chromosome of BL892 (Fig. 8A). Different 
mutL chimeric genes were generated as a result of integration of pDE-MutLET-5 into the host 
chromosome. Regions where recombination occurred were mapped in the different cointegrant 
strains by PCR-restriction analysis (Fig. 8B). This analysis demonstrated that recombination 
occurred very close to the 5’-end of mutL gene (within the 154 bp HinfI fragment) in 
BL892ΩmutLET-5-2 (Fig. 8A and B, lane 6), within the 5’-end-proximal 503 bp HinfI fragment 
in both BL892ΩmutLET-5-14 and BL892ΩmutLET-5-15 (Fig. 8A and B, lanes 4 and 5, 
respectively), within the central 630 bp HinfI fragment in BL892ΩmutLET-5-13 (Fig. 8A and 
data not shown), and within the 3’-end-proximal 689 bp fragment in BL892ΩmutLET-5-6 (Fig. 
8A and data not shown). Mapping by PCR-restriction was confirmed by Southern blot analysis 
(data not shown). In strains BL892ΩmutLET-5-2, BL892ΩmutLET-5-14 and BL892ΩmutLET-5-
15 the mutator phenotype of BL892 was suppressed as well as in BL892 mutLET-5 (Table 4). In 
contrast, BL892ΩmutLET-5-6 and BL892ΩmutLET-5-13 exhibited the same mutability as the 
parental BL892 (Table 4). The result of this analysis restricted to four (S395A, Y397R, R402H 
and F433L) the number of amino acid substitutions eventually responsible for the mutator 
phenotype, the remaining being also present in non-mutator strains. As all these amino acid 
substitutions affected residues that are not evolutionarily conserved in Gram-negative bacteria 
(data not shown), the molecular basis for the biochemical defect of the mutL allele from BL892 
was not obvious. However, in silico analysis of the coiled coils distribution in the MutL 
peptides using the Lupas algorithm (Lupas et al., 1991) predicted that the F433L substitution in 
BL892 had the potential to alter locally the secondary structure of the protein (Fig. 9).  By 
using the same strategy, mutL allele from MC58 was used to generate cointegrates with the 
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chromosome of BL942. However, in this case, suppression of the mutator phenotype was never 
observed in any cointegrant strains (data not shown),  possibly due to the presence of the out-
of-frame mutS allele (Fig. 6).We did not extend this analysis to BL951 because of its weak 
mutator phenotype that was expected to give inconclusive (statistically ambiguous) results.  
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Figure 8. Generation of cointegrant strains by recombination in the mutL locus of BL892.  
 
(A) Experimental design for integration of plasmid pDE-MutLET-5 into the chromosome of 
BL892 and strategy to map the integration sites by PCR-restriction analysis. Location of the 
primer pair (arrows) and the HinfI (Hf) restriction sites for PCR-restriction analysis (B), and 
the distribution of missense mutations (bar) in mutL alleles (see Table 3) are reported. The 
integration sites in strains BL892ΩmutLET-5-2 (2), BL892ΩmutLET-5-6 (6), BL892ΩmutLET-5-
13 (13), BL892ΩmutLET-5-14 (14) and BL892ΩmutLET-5-15 (15) are indicated.  
(B) PCR-restriction analysis. Total DNAs derived from BL892 (lane 2), MC58 (lane 3), 
BL892ΩmutLET-5-14 (lane 4), BL892ΩmutLET-5-15 (lane 5) and BL892ΩmutLET-5-2 (lane 6) 
were used as templates in PCR reaction with the primer pair (mutL1 and mutL2Bam) indicated 
above (A). The PCR products were purified and digested with HinfI and analyzed by agarose 
gel. In lane 1 DNA molecular weight ladders were run in parallel, and their relative migration 
is reported on the left. The sizes of mutL-specific fragments are indicated on the right. 
Asterisks indicate partially digested fragments. 
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 Figure 9. Coiled coil profiles of MutL deduced amino acid sequences.  
 
Prediction of coiled coils from protein sequences was obtained using the Lupas algorithm 
(Lupas et al., 1991) as detailed in Materials and Metods. 
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Genetic interaction between mutLBL892 and recBET-37 alleles  
 
In a previous work we demonstrated that, when introduced in the mismatch repair-proficient 
strain MC58, the defective recBET-37 allele did not affect the spontaneous mutability to 
rifampicin-resistance (Salvatore et al., 2002). We performed the same experiment with the 
mismatch repair-defective strain BL892. To this purpose, isogenic derivatives BL892 recBET-37   
were generated by allelic replacement of the wild-type recB with the recBET-37   one using a 
previously described procedure (Salvatore et al., 2002). Transformants were selected by 
replica-plating selecting for increased UV-sensitivity. The results of Southern blot analysis 
confirmed that in all UV-sensitive clones the recBET-37 allele replaced the functional recB allele 
(data not shown). Using the same approach we attempted the same gene replacement in 
BL942, exhibiting a stronger mutator phenotype than BL892. However, we failed to obtain 
recombinants even if a large number of colonies were screened for UV-sensitivity (data not 
shown). In agreement with previous data (Salvatore et al., 2002) replacement of the wild-type 
recB allele with the defective recBET-37 one generated recombinant strains exhibiting moderate 
decrease in viability (Table 5). The recombinant strains also exhibited dramatic increase in 
sensitivity to hydrogen peroxide exposure. Both these effects could be detected in all strains 
even though they were more severe in MC58. In Table 5 the results of mutagenicity assay 
demonstrated that replacement of the wild-type recB allele with the recBET-37 one caused 
suppression of the mutator phenotype observed in BL892, whereas it did not affect the 
mutability of MC58.  
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Table 5. Effects of recB allelic replacement on meningococcal viability, mutability and 
sensitivity to hydrogen peroxide 
 
 
Strain 
Viabilitya
Viability upon 
hydrogen peroxide 
exposureb
Spontaneous mutation 
frequencyc
per 109 cells, median 
n° 
MC58 1.00 1.00 2.39 
MC58 recBET-37 0.41 0.02 2.22 
MC58ΩrecB 0.44 0.02 2.27 
BL892 0.85 0.77 5.67 
BL892 recBET-37 0.60 0.14 1.97 
BL892ΩrecB 0.62 0.16 1.96 
 
 
a Viabilities of meningococcal strains were determined by counting the number of viable cells 
(cfu) in late exponential phase cultures (O.D.550 nm = 1.0) in GC medium with 1% (v/v) 
Polyvitox. 
b Viabilities of meningococcal were determined after 30 min treatment of logarithmic growing 
bacteria (O.D.550 nm = 0.5) with 200 μM hydrogen peroxide. 
c Mutation frequencies to rifampicin resistance were determined as described in the footnote to 
Table 2. 
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Insertional recB inactivation  
 
To clarify whether suppression of the mutL-induced mutator phenotype by the defective 
recBET-37 was allele-specific or not, we attempted to generate null recB allele in mutLBL892 
background. To this purpose, pDEΔ-RecB, harbouring the central coding region of recB from 
MC58, was used to transform BL892 and MC58 (Fig. 10). Transformation of MC58 resulted in 
insertional recB inactivation in almost all transformants (MC58ΩrecB). As a result of the 
recombination event, two HincII DNA fragments of the expected sizes (5954 and 2467 bp) 
were detected by recB-specific probe (Fig. 10B, lanes 2–8), in place of the 3293 bp-long 
HincII fragment of the parental strain MC58 (Fig. 10B, lane 1). By contrast, the same 
procedure led to recB inactivation only in a single BL892 transformant, BL892ΩrecB (Fig. 
10B, lane 12). BL892ΩrecB and MC58ΩrecB exhibited almost the same UV-sensitivity, 
viability, mutability and sensitivity to hydrogen peroxide exposure as BL892 recBET-37 and 
MC58 recBET-37, respectively (Table 5 and data not shown). These findings suggested that 
recBET-37 was a null allele, and that suppression of the mutL-induced mutator phenotype by 
recBET-37 was not allele-specific. 
 
 
 
 
 
 
 
 
 
 
 63
  
 
Figure 10. recB knock-out 
(A) Experimental design for insertional recB inactivation by single cross-over using pDEΔ-
RecB. Locations of chromosomal/plasmid HincII (Hc) and plasmid HindIII (Hd) restriction 
sites and of DNA probe (black rectangle) used in Southern blot experiment (B) are shown.  
(B) Southern blot analysis. Total DNAs derived from MC58 (lane 1), BL892 (lane 9) and from 
erythromycin-resistant MC58 and BL892 derivatives transformed with pDEΔ-RecB (lanes 2-8 
and 10-16, respectively) were digested with HincII and analyzed by Southern blot using the 
DNA probe indicated in A. Relative migration of DNA molecular weight ladders is reported on 
the left. Arrowheads indicate recB-specific fragments. 
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DISCUSSION 
 
In this study we demonstrate that several invasive serogroup B meningococcal strains 
phylogenetically related to the lineage III exhibit a mutator phenotype (Table 2). The mutator 
phenotype was due to the presence of mutL and/or mutS defective mosaic alleles. The strain 
BL942 exhibited the strongest mutator phenotype. In this strain a loss-of-function mismatch 
mutation in mutS (Fig. 6) generated mutator levels comparable to those measured in 93/4286 
(Table 2), an ET-37 strain carrying an IS1106 insertion in the mutS coding region destroying 
the ATPase domain (Fig. 6). In addition to mutS mutation, BL942 also carried a mutL allele 
harbouring multiple missense mutations mostly coinciding with those previously identified in 
other mutator strains (Richardson & Stojiljkovic, 2001) (Table 3). Most of these amino acid 
substitutions were also present in BL892, a lineage III strain exhibiting a moderate phenotype 
(Table 2) with a functional mutS gene. The other lineage III strains carried mosaic mutL alleles 
and were not mutator. The results of mutagenicity assays (Table 4) after mutL allelic 
replacement (Fig. 7) demonstrated that the enhanced mutability of BL892 strain was the result 
of non- or less-functional mutL allele. The analysis of mutability of cointegrant strains 
harbouring chimeric mutL genes (Fig. 8 and Table 4) restricted to four (S395A, Y397R, R402H 
and F433L) (Table 3) the number of amino acid substitutions eventually responsible for the 
mutator phenotype. These substitutions map in the extended linker region between the N-
terminal ATPase and C-terminal dimerization domains sharing no similarity between MutL 
homologues (Ban & Yang, 1998; Ban et al., 1999; Guarné et al., 2004). This region generates a 
large cavity in MutL dimers encircling DNA duplexes and tolerates sequence substitutions and 
deletions of one-third of its length without functional consequences (Guarné et al., 2004). In 
mismatch-proficient meningococcal strains the MutL linker region spans 114 residues between 
the amino acids 348 and 461 (332-431 in E. coli MutL) and it was predicted to form random 
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coils (Fig. 9 and data not shown) as well as in all MutL homologues (Guarné et al., 2004). In 
silico analysis of the coiled coils distribution in the MutL peptides using the Lupas algorithm 
(Lupas et al., 1991) predicted that the F433L substitution in BL892 had the potential to alter 
locally the secondary structure of the protein by enhancing dramatically the possibility to form 
coiled coils structure in the region spanning the amino acids 395-445 (Fig. 9). It should be 
interesting to test whether the extra coiled coils structure affects the biochemical activities of 
the MutL protein including ATPase, DNA binding, dimerization and interaction with the UvrD 
helicase (Ban & Yang, 1998; Ban et al., 1999; Guarné et al., 2004; Hall et al., 1998). However 
the evidence that deletions in the extended linker may be defective in mismatch repair in vivo 
in spite of normal ATPase and DNA binding activities (Guarné et al., 2004) recommends 
caution when using in vitro approaches. 
An interesting point of this study is the evidence that the mutator phenotype of the mutL-
defective strain BL892 may be suppressed by replacement of the functional recB allele with 
the non-functional recBET-37 one or by insertional inactivation of recB (Table 5). This result 
demonstrates the existence of multiple links connecting recombination and mutation in N. 
meningitidis. One of such links has been previously explored when phase variation frequencies 
were shown to be increased in mismatch-repair proficient meningococcal strains by 
transformation with heterologous DNA as a consequence of titration of some component of the 
mismatch repair machinery (Alexander et al., 2004). 
In pathogenic Neisseriae the RecBCD pathway is involved in genetic transformation (Mehr & 
Seifert, 1998; Salvatore et al., 2002; Skaar et al., 2002; Kline et al., 2003), in pilin phase 
variation (Chaussee et al., 1999; Salvatore et al., 2002), and in recombinational repair (Mehr & 
Seifert, 1998; Salvatore et al., 2002; Skaar et al., 2002; Kline et al., 2003). There is evidence 
that the RecBCD pathway is mostly important for structural maintenance of chromosome 
replication upon fork collapse (Kuzminov, 1999). Unrepaired oxidative damage is the major 
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cause of replication fork collapse (Kuzminov, 1999), and this may be the reason why MC58 
recBET-37 and BL892 recBET-37 were much more sensitive to exposure to hydrogen peroxide 
and were less viable than their isogenic recB-proficient counterparts (Table 5). Similar 
phenotypes were observed in E. coli recA or recBC (Ananthaswamy & Eisenstark, 1977; 
Carlsson & Carpenter, 1980) as well as in gonococcal priA mutants (Kline & Seifert, 2005). 
In principle, suppression of the mutator phenotype by recB allelic replacement may be 
explained by “physical” interaction between MutL and RecB proteins along an uncharacterized 
mutagenic pathway. Although a similar pathway has not been found in E. coli, we cannot 
exclude that it may exist in N. meningitidis, a microorganism in which several DNA repair 
genes do not exist and the gene products of others interact differently when compared to E. coli 
(Davidsen & Tonjum, 2006). Alternatively, we hypothesize a “functional” interaction between 
MutL and RecB along well-established pathways. Indeed our data may suggest that in a 
mismatch repair-defective background mutability is mostly generated during DNA synthesis 
associated to RecBCD-dependent processes, such as reassembling of disintegrated replication 
forks. There is analogy between the mutagenesis pathway we describe and two distinct 
mutagenesis pathways of E. coli in their apparent requirement for RecBCD-dependent 
recombination pathway: translational stress-induced mutagenesis (TSM) (Balashov & 
Humayun, 2002; Mamun et al., 2002) and stationary-phase (adaptive) mutagenesis (Foster, 
1999; Foster, 2000; Rosenberg, 2001). In particular, TSM refers to elevated mutagenesis 
observed in E. coli cells in which mistranslation has been increased as a result of mutations in 
tRNA genes or by exposure to streptomycin. TSM does not require the induction of lexA/recA-
regulated SOS genes (at variance with stationary-phase mutagenesis), is suppressed in cells 
defective for RecABC/RuvABC-dependent homologous recombination, and is mediated by an 
error-prone form of DNA pol III* (Balashov & Humayun, 2002; Mamun et al., 2002). 
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Understanding the relationship between these pathways and the meningococcal RecB-
dependent mutagenic pathway in mutLET-24 genetic background deserves future investigation. 
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